Anti-myelin oligodendrocyte glycoprotein B-cell responses in multiple sclerosis

J Neuroimmunol. 2003 Feb;135(1-2):117-25. doi: 10.1016/s0165-5728(02)00434-4.

Abstract

Humoral auto-immunity to the myelin oligodendrocyte glycoprotein (MOG) is likely involved in the pathogenesis of multiple sclerosis (MS). In 44 MS patients and 30 controls, Ig-producing B cells were identified by their isotype and as MOG-specific spot-forming cells (SFC). Peripheral anti-MOG antibodies were assayed in ELISA as well as anti-butyrophilin antibodies to investigate for molecular mimicry. MS patients had significantly higher levels of IgA- and MOG-SFC than controls, as well as significantly higher antibody responses to MOG and butyrophilin. These data provide added support for the implication of anti-MOG humoral immunity in the pathophysiology of MS, and suggest a balance of systemic (anti-self) and mucosal (environment-modulated) immune reactions in an attempt at regulating the pathogenic specific immune response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Antibody-Producing Cells / physiology
  • B-Lymphocytes / immunology*
  • Butyrophilins
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Flow Cytometry
  • Humans
  • Immunoglobulin Isotypes / blood
  • Male
  • Membrane Glycoproteins / immunology
  • Middle Aged
  • Multiple Sclerosis / immunology*
  • Multiple Sclerosis / therapy
  • Myelin Proteins
  • Myelin-Associated Glycoprotein / immunology*
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments / immunology
  • Transforming Growth Factor beta / blood

Substances

  • Butyrophilins
  • Immunoglobulin Isotypes
  • MOG protein, human
  • Membrane Glycoproteins
  • Myelin Proteins
  • Myelin-Associated Glycoprotein
  • Myelin-Oligodendrocyte Glycoprotein
  • Peptide Fragments
  • Transforming Growth Factor beta